Haw ParHAWPF 96 Days Payable is 159.69 as of Dec. 2025, which is 883% above its 10-year median of 16.24. GuruFocus rates HAWPF with a GF Score™ of 96/100 and a GF Value™ of $8.94. The stock has 3 warning signs investors should review. Among 920 Drug Manufacturers companies, Haw Par ranks better than 56.41% on this metric.
Haw Par's average Accounts Payable for the
six
months ended in Dec. 2025 was $31.4 Mil. Haw Par's Cost of Goods Sold for the
six
months ended in Dec. 2025 was $35.9 Mil.
Hence, Haw Par's Days Payable for the
six
months ended in Dec. 2025 was 159.69.
The historical rank and industry rank for Haw Par's Days Payable or its related term are showing as below:
HAWPF'
s Days Payable Range Over the Past 10 Years
Min: 13.75 Med: 16.24 Max: 102.18
Current: 102.18
During the past 13 years, Haw Par's highest Days Payable was 102.18. The lowest was 13.75. And the median was 16.24.
HAWPF's Days Payable is ranked better than 56.41% of 920
companies
in the Drug Manufacturers industry
Industry Median: 90.835
vs HAWPF: 102.18
Haw Par's Days Payable
increased
from Dec. 2024 (121.07) to Dec. 2025 (159.69).
It may suggest that Haw Pardelayed paying its suppliers.
Haw Par Days Payable Related Terms
Haw Par Days Payable Historical Data
* Premium members only.
The historical data trend for Haw Par's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - General subindustry, Haw Par's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Haw Par Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Haw Par's Days Payable distribution charts can be found below:
* The bar in red indicates where Haw Par's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Haw Par's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Haw Par (HAWPF) has a Days Payable of 159.69 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Haw Par and its competitors. This is 883% above median its historical median of 16.24. Over the past decade, Haw Par's Days Payable has ranged from 13.75 to 102.18. According to the industry distribution chart, Haw Par ranks #401 out of 920 companies in the Drug Manufacturers industry, placing it in the top 43.6%.
Is Haw Par's Days Payable too high?
Haw Par's current Days Payable of 159.69 is 883% above median its 10-year median of 16.24. Over the past 10 years, this metric has ranged from a low of 13.75 to a high of 102.18. The Drug Manufacturers industry median Days Payable is 90.84. Haw Par's value of 159.69 is 75.8% above this industry median. Based on the distribution chart, Haw Par ranks #401 out of 920 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Haw Par has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does Haw Par's Days Payable compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Haw Par ranks #401 out of 920 companies for Days Payable. This puts Haw Par in the upper half of its industry. The industry median Days Payable is 90.84. Haw Par's value of 159.69 is 75.8% above this benchmark. Historically, Haw Par's own Days Payable has ranged from 13.75 to 102.18 over the past decade. While the company's 10-year median is 16.24 vs. the industry median of 90.84, Haw Par has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.84, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Haw Par's current Days Payable of 159.69 is 75.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Haw Par and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.84 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Haw Par's current Days Payable is 159.69, which is 883% above median its own 10-year median of 16.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Haw Par stock overvalued right now?
Haw Par (HAWPF) has a current Days Payable of 159.69. The stock's GF Value™ is $8.94, compared to a current price of $12.00 — trading 34.2% above its estimated fair value. The current Days Payable is 159.69, which is 883% above median its 10-year median of 16.24 and 75.8% above the Drug Manufacturers industry median of 90.84. Haw Par's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Haw Par (HAWPF), the current Days Payable is 159.69 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Haw Par (HAWPF) Overvalued in 2026?
Based on GuruFocus' analysis, Haw Par stock appears to be overvalued.
The current stock price of $12.00 is trading 34.2% above its estimated GF Value™ of $8.94.
Key valuation signals for HAWPF:
Days Payable: 159.69 (883% above median its 10-year median of 16.24)
GF Value™: $8.94 vs. price of $12.00 (34.2% above fair value)
Industry Position: 75.8% above the Drug Manufacturers median (#401 of 920)
No single metric tells the full story. See the HAWPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Haw Par Corp Ltd is a drug manufacturing company that operates multiple brands. The company is to expand its core businesses through product brand extension, strategic alliances, and exploring potential acquisitions. Its operating segments include the Healthcare segment, Investments segment, Property segment, and Leisure segment. The company generates the majority of its revenue from the Healthcare segment. Its Healthcare segment manufactures and distributes topical analgesic products under the Tiger Balm and Kwan Loong brands. Geographically, it generates key revenue from the other ASEAN and other Asian countries.
96GF Score
Get the complete analysis for HAWPF
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAWPF has been successfully added to your 
